Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User fee rate hike for fiscal 2005

Executive Summary

FDA increases Prescription Drug User Fee Act rates 17% for fiscal year 2005 to $672,000 for an application including clinical data and $336,000 for an application not requiring clinical data or a supplement requiring clinical data. The agency estimates that it will receive 147 fee-paying applications in fiscal 2005...

FDA increases Prescription Drug User Fee Act rates 17% for fiscal year 2005 to $672,000 for an application including clinical data and $336,000 for an application not requiring clinical data or a supplement requiring clinical data. The agency estimates that it will receive 147 fee-paying applications in fiscal 2005....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel